Clinical and Translational Study of STA-9090
NCT01111838
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer
Rectal Cancer
Interventions
DRUG:
STA-9090
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]